A slew of contemporary research suggests MDMA’s efficacy as an adjunct in the treatment of PTSD, while little is known concerning the mechanisms at work.

Recent investigation into the behavioral neurobiology of MDMA’s ability to facilitate the cessation of fear responses may offer a mechanistic explanation regarding its psychiatric utility.

This scientific paper discusses the effect of the mystical experience in the therapeutic process and how anxiety may even serve to facilitate.

The author illustrates how psychedelic drugs inspire outside-the-box thinking.

Thinking about trying Ibogaine?   Know about the risk of arrhythmia.

What causes mushrooms to behave the way they do?  PhD candidate Tyler Quigley postulates about fungal behavior.